Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Fortunato Ciardiello

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Living Beings

Anatomy

Cultured Tumor Cells

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
95
Tortora, Giampaolo
55
Bianco, Angelo Raffaele
42
Bianco, Roberto
41
Damiano, Vincenzo
37
Salomon, David
33
De Placido, Sabino
31
Caputo, Rosa
28
Pepe, Stefano
25
Normanno, Nicola
25
De Vita, Ferdinando
24
Orditura, Michele
22
Troiani, Teresa
18
Fontanini, Gabriella
15
Morgillo, Floriana
14
Catalano, Giuseppe

Sign-in to see all Coauthors

Publications

TOP 3
Martinelli E; De Palma R; Orditura M; De Vita F; Ciardiello F
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy.
Morelli M Pia; Brown Amy M; Pitts Todd M; Tentler John J; Ciardiello Fortunato; Ryan Anderson; Jürgensmeier Juliane M; Eckhardt S Gail
Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.
Normanno Nicola; Tejpar Sabine; Morgillo Floriana; De Luca Antonella; Van Cutsem Eric; Ciardiello Fortunato
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Fortunato Ciardiello (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Martinelli E; De Palma R; Orditura M; De Vita F; Ciardiello F
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy.
Clinical and experimental immunology 2009;158(1):1-9.
2009: Morelli M Pia; Brown Amy M; Pitts Todd M; Tentler John J; Ciardiello Fortunato; Ryan Anderson; Jürgensmeier Juliane M; Eckhardt S Gail
Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.
Molecular cancer therapeutics 2009;8(9):2546-58.
2009: Normanno Nicola; Tejpar Sabine; Morgillo Floriana; De Luca Antonella; Van Cutsem Eric; Ciardiello Fortunato
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.
Nature reviews. Clinical oncology 2009;6(9):519-27.
2009: Vecchione Loredana; Orditura Michele; Ciardiello Fortunato; De Vita Ferdinando
Novel investigational drugs for gastric cancer.
Expert opinion on investigational drugs 2009;18(7):945-55.
2009: Orditura Michele; De Vita Ferdinando; Galizia Gennaro; Lieto Eva; Vecchione Loredana; Vitiello Fabiana; Martinelli Erika; Ciardiello Fortunato
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis.
Oncology reports 2009;21(4):1023-8.
2009: Gridelli Cesare; Maione Paolo; Rossi Antonio; Ferrara Marianna Luciana; Bareschino Maria Anna; Schettino Clorinda; Sacco Paola Claudia; Ciardiello Fortunato
Potential treatment options after first-line chemotherapy for advanced NSCLC: maintenance treatment or early second-line?
The oncologist 2009;14(2):137-47.
2008: Tortora Giampaolo; Ciardiello Fortunato; Gasparini Giampietro
Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
Nature clinical practice. Oncology 2008;5(9):521-30.
2008: Cascone Tina; Morelli Maria Pia; Morgillo Floriana; Kim Woo-Young; Rodolico Gabriella; Pepe Stefano; Tortora Giampaolo; Berrino Liberato; Lee Ho-Young; Heymach John V; Ciardiello Fortunato
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells.
Journal of cellular physiology 2008;216(3):698-707.
2008: Bianco Roberto; Rosa Roberta; Damiano Vincenzo; Daniele Gennaro; Gelardi Teresa; Garofalo Sonia; Tarallo Valeria; De Falco Sandro; Melisi Davide; Benelli Roberto; Albini Adriana; Ryan Anderson; Ciardiello Fortunato; Tortora Giampaolo
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5069-80.
2008: Gelardi T; Caputo R; Damiano V; Daniele G; Pepe S; Ciardiello F; Lahn M; Bianco R; Tortora G
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
British journal of cancer 2008;99(3):473-80.
2008: Gridelli Cesare; Butts Charles; Ciardiello Fortunato; Feld Ronald; Gallo Ciro; Perrone Francesco
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial.
Clinical lung cancer 2008;9(4):235-8.
2008: Schettino Clorinda; Bareschino Maria A; Maione Paolo; Rossi Antonio; Ciardiello Fortunato; Gridelli Cesare
The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer.
Current genomics 2008;9(4):252-62.
2008: Morgillo Floriana; Martinelli Erika; Troiani Teresa; Laus Gianluca; Pepe Stefano; Gridelli Cesare; Ciardiello Fortunato
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells.
Molecular cancer therapeutics 2008;7(6):1698-707.
2008: Gridelli Cesare; Ardizzoni Andrea; Ciardiello Fortunato; Hanna Nasser; Heymach John V; Perrone Francesco; Rosell Rafael; Shepherd Frances A; Thatcher Nick; Vansteenkiste Johan; De Petris Luigi; Di Maio Massimo; De Marinis Filippo
Second-line treatment of advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):430-40.
2008: Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema M R; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
Cancer investigation 2008;26(3):250-5.
2008: Troiani Teresa; Schettino Clorinda; Martinelli Erika; Morgillo Floriana; Tortora Giampaolo; Ciardiello Fortunato
The use of xenograft models for the selection of cancer treatments with the EGFR as an example.
Critical reviews in oncology/hematology 2008;65(3):200-11.
2008: Ciardiello Fortunato; Tortora Giampaolo
EGFR antagonists in cancer treatment.
The New England journal of medicine 2008;358(11):1160-74.
2008: Bianco R; Garofalo S; Rosa R; Damiano V; Gelardi T; Daniele G; Marciano R; Ciardiello F; Tortora G
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs.
British journal of cancer 2008;98(5):923-30.
2007: Veneziani Bianca Maria; Criniti Vittoria; Cavaliere Carla; Corvigno Sara; Nardone Agostina; Picarelli Silvia; Tortora Giampaolo; Ciardiello Fortunato; Limite Gennaro; De Placido Sabino
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches.
Molecular cancer therapeutics 2007;6(12 Pt 1):3091-100.
2007: Federico Alessandro; Morgillo Floriana; Tuccillo Concetta; Ciardiello Fortunato; Loguercio Carmela
Chronic inflammation and oxidative stress in human carcinogenesis.
International journal of cancer. Journal international du cancer 2007;121(11):2381-6.
2007: Gridelli Cesare; Rossi Antonio; Morgillo Floriana; Bareschino Maria Anna; Maione Paolo; Di Maio Massimo; Ciardiello Fortunato
A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamics.
Clinical lung cancer 2007;8(9):568-71.
2007: Tabernero Josep; Van Cutsem Eric; Díaz-Rubio Eduardo; Cervantes Andrés; Humblet Yves; André Thierry; Van Laethem Jean-Luc; Soulié Patrick; Casado Esther; Verslype Chris; Valera Javier Sastre; Tortora Giampaolo; Ciardiello Fortunato; Kisker Oliver; de Gramont Aimery
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5225-32.
2007: Troiani Teresa; Serkova Natalie J; Gustafson Daniel L; Henthorn Thomas K; Lockerbie Owen; Merz Andrea; Long Michael; Morrow Mark; Ciardiello Fortunato; Eckhardt S Gail
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6450-8.
2007: Morgillo Floriana; Bareschino Maria Anna; Bianco Roberto; Tortora Giampaolo; Ciardiello Fortunato
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy.
Differentiation; research in biological diversity 2007;75(9):788-99.
2007: De Vita F; Giuliani F; Orditura M; Maiello E; Galizia G; Di Martino N; Montemurro F; Cartenì G; Manzione L; Romito S; Gebbia V; Ciardiello F; Catalano G; Colucci G;
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1354-8.
2007: Gridelli Cesare; Bareschino Maria Anna; Schettino Clorinda; Rossi Antonio; Maione Paolo; Ciardiello Fortunato
Erlotinib in non-small cell lung cancer treatment: current status and future development.
The oncologist 2007;12(7):840-9.
2007: Damiano Vincenzo; Caputo Rosa; Garofalo Sonia; Bianco Roberto; Rosa Roberta; Merola Gerardina; Gelardi Teresa; Racioppi Luigi; Fontanini Gabriella; De Placido Sabino; Kandimalla Ekambar R; Agrawal Sudhir; Ciardiello Fortunato; Tortora Giampaolo
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(30):12468-73.
2007: Bareschino M A; Schettino C; Troiani T; Martinelli E; Morgillo F; Ciardiello F
Erlotinib in cancer treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi35-41.
2007: Orditura M; Martinelli E; Galizia G; Vitiello F; Fasano M; Muto P; Ciardiello F; De Vita F
Chemoradiotherapy as adjuvant treatment of gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi133-5.
2007: De Vita F; Giuliani F; Galizia G; Belli C; Aurilio G; Santabarbara G; Ciardiello F; Catalano G; Orditura M
Neo-adjuvant and adjuvant chemotherapy of gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi120-3.
2007: Cappuzzo Federico; Ligorio Claudia; Jänne Pasi A; Toschi Luca; Rossi Elisa; Trisolini Rocco; Paioli Daniela; Holmes Alison J; Magrini Elisabetta; Finocchiaro Giovanna; Bartolini Stefania; Cancellieri Alessandra; Ciardiello Fortunato; Patelli Marco; Crino Lucio; Varella-Garcia Marileila
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2248-55.
2007: Gridelli Cesare; Gallo Ciro; Ceribelli Anna; Gebbia Vittorio; Gamucci Teresa; Ciardiello Fortunato; Carozza Francesco; Favaretto Adolfo; Daniele Bruno; Galetta Domenico; Barbera Santi; Rosetti Francesco; Rossi Antonio; Maione Paolo; Cognetti Francesco; Testa Antonio; Di Maio Massimo; Morabito Alessandro; Perrone Francesco;
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
The lancet oncology 2007;8(6):500-12.
2007: Tortora Giampaolo; Bianco Roberto; Daniele Gennaro; Ciardiello Fortunato; McCubrey James A; Ricciardi Maria Rosaria; Ciuffreda Ludovica; Cognetti Francesco; Tafuri Agostino; Milella Michele
Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(3):81-100.
2007: Gridelli Cesare; Rossi Antonio; Mongillo Floriana; Bareschino Maria; Maione Paolo; Ciardiello Fortunato
A randomized phase II study of sorafenib/gemcitabine or sorafenib/erlotinib for advanced non-small-cell lung cancer in elderly patients or patients with a performance status of 2: treatment rationale and protocol dynamics.
Clinical lung cancer 2007;8(6):396-8.
2007: Galizia G; Lieto E; De Vita F; Orditura M; Castellano P; Troiani T; Imperatore V; Ciardiello F
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer.
Oncogene 2007;26(25):3654-60.
2007: Morgillo Floriana; Kim Woo-Young; Kim Edward S; Ciardiello Fortunato; Hong Waun Ki; Lee Ho-Young
Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(9):2795-803.
2007: Bareschino Maria Anna; Morgillo Floriana; Ciardiello Fortunato
Combination of standard chemotherapy and targeted agents.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5 Suppl):S19-23.
2007: Cascone Tina; Gridelli Cesare; Ciardiello Fortunato
Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Current opinion in oncology 2007;19(2):98-102.
2007: Tortora G; Gelardi T; Ciardiello F; Bianco R
The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy.
The International journal of biological markers 2007;22(1 Suppl 4):S47-52.
2007: Bianco Roberto; Damiano Vincenzo; Gelardi Teresa; Daniele Gennaro; Ciardiello Fortunato; Tortora Giampaolo
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling.
Current pharmaceutical design 2007;13(33):3358-67.
2007: Bianco Roberto; Gelardi Teresa; Damiano Vincenzo; Ciardiello Fortunato; Tortora Giampaolo
Rational bases for the development of EGFR inhibitors for cancer treatment.
The international journal of biochemistry & cell biology 2007;39(7-8):1416-31.
2007: Orditura Michele; Lieto Eva; Ferraraccio Francesca; De Cataldis Giuseppe; Troiani Teresa; Castellano Paolo; Catalano Giuseppe; Ciardiello Fortunato; Galizia Gennaro; De Vita Ferdinando
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass.
World journal of surgical oncology 2007;5():42.
2006: Bianco Cataldo; Giovannetti Elisa; Ciardiello Fortunato; Mey Valentina; Nannizzi Sara; Tortora Giampaolo; Troiani Teresa; Pasqualetti Francesco; Eckhardt Gail; de Liguoro Mario; Ricciardi Simona; Del Tacca Mario; Raben David; Cionini Luca; Danesi Romano
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7099-107.
2006: Orditura M; Martinelli E; Galizia G; Carlomagno C; Aurilio G; Vecchione L; Lieto Eva; De Placido S; Catalano G; Ciardiello F; De Vita F
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1529-32.
2006: Morelli Maria Pia; Cascone Tina; Troiani Teresa; Tuccillo Concetta; Bianco Roberto; Normanno Nicola; Romano Marco; Veneziani Bianca Maria; Fontanini Gabriella; Eckhardt S Gail; De Pacido Sabino; Tortora Giampaolo; Ciardiello Fortunato
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases.
Journal of cellular physiology 2006;208(2):344-53.
2006: Troiani Teresa; Lockerbie Owen; Morrow Mark; Ciardiello Fortunato; Eckhardt S Gail
Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases.
Molecular cancer therapeutics 2006;5(7):1883-94.
2006: Ciardiello F; Troiani T; Bianco R; Orditura M; Morgillo F; Martinelli E; Morelli M P; Cascone T; Tortora G
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii109-14.
2006: Ciardiello F; Troiani T; Caputo F; De Laurentiis M; Tortora G; Palmieri G; De Vita F; Diadema M R; Orditura M; Colantuoni G; Gridelli C; Catalano G; De Placido S; Bianco A R
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
British journal of cancer 2006;94(11):1604-9.
2006: Galizia Gennaro; Lieto Eva; Ferraraccio Francesca; De Vita Ferdinando; Castellano Paolo; Orditura Michele; Imperatore Vincenzo; La Mura Anna; La Manna Giovanni; Pinto Margherita; Catalano Giuseppe; Pignatelli Carlo; Ciardiello Fortunato
Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
Annals of surgical oncology 2006;13(6):823-35.
2006: Cascone T; Morelli M P; Ciardiello F
Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii46-48.
2006: Maione Paolo; Gridelli Cesare; Troiani Teresa; Ciardiello Fortunato
Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
The oncologist 2006;11(3):274-84.
2006: Galizia Gennaro; Ferraraccio Francesca; Lieto Eva; Orditura Michele; Castellano Paolo; Imperatore Vincenzo; La Manna Giovanni; Pinto Margherita; Ciardiello Fortunato; La Mura Anna; De Vita Ferdinando
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Journal of surgical oncology 2006;93(3):241-52.
2006: Cascone Tina; Troiani Teresa; Morelli Maria Pia; Gridelli Cesare; Ciardiello Fortunato
Antiangiogenic drugs in non-small cell lung cancer treatment.
Current opinion in oncology 2006;18(2):151-5.
2006: Carlomagno Chiara; Orditura Michele; Pepe Stefano; De Vita Ferdinando; Romano Carmela; Ciardiello Fortunato; Ferrara Claudia; Martinelli Erika; Bianco Roberto; Aurilio Gaetano; D'Agostino Diego; Tortora Giampaolo; Catalano Giuseppe; De Placido Sabino
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study.
American journal of clinical oncology 2006;29(1):85-9.
2006: Bianco Roberto; Melisi Davide; Ciardiello Fortunato; Tortora Giampaolo
Key cancer cell signal transduction pathways as therapeutic targets.
European journal of cancer (Oxford, England : 1990) 2006;42(3):290-4.
2006: Damiano Vincenzo; Caputo Rosa; Bianco Roberto; D'Armiento Francesco P; Leonardi Antonio; De Placido Sabino; Bianco A Raffaele; Agrawal Sudhir; Ciardiello Fortunato; Tortora Giampaolo
Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):577-83.
2006: Frederick Barbara; Gustafson Dan; Bianco Cataldo; Ciardiello Fortunato; Dimery Isaiah; Raben David
ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy.
International journal of radiation oncology, biology, physics 2006;64(1):33-7.
2005: Melisi Davide; Caputo Rosa; Damiano Vincenzo; Bianco Roberto; Veneziani Bianca Maria; Bianco A Raffaele; De Placido Sabino; Ciardiello Fortunato; Tortora Giampaolo
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
Endocrine-related cancer 2005;12(4):1051-8.
2005: Di Maio Massimo; Gridelli Cesare; Normanno Nicola; Perrone Francesco; Ciardiello Fortunato
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Journal of cellular physiology 2005;205(3):355-63.
2005: Tuccillo Concetta; Cuomo Antonio; Rocco Alba; Martinelli Erika; Staibano Stefania; Mascolo Massimo; Gravina Antonietta G; Nardone Gerardo; Ricci Vittorio; Ciardiello Fortunato; Del Vecchio Blanco Camillo; Romano Marco
Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans.
The Journal of pathology 2005;207(3):277-84.
2005: Ciardiello Fortunato; Ma Brigette
[EGF receptor blockade with monoclonal antibodis and so-called "small molecules"]
Onkologie 2005;28 Suppl 4():18-24.
2005: Damiano Vincenzo; Melisi Davide; Bianco Cataldo; Raben David; Caputo Rosa; Fontanini Gabriella; Bianco Roberto; Ryan Anderson; Bianco A Raffaele; De Placido Sabino; Ciardiello Fortunato; Tortora Giampaolo
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5639-44.
2005: Bianco Roberto; Troiani Teresa; Tortora Giampaolo; Ciardiello Fortunato
Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy.
Endocrine-related cancer 2005;12 Suppl 1():S159-71.
2005: De Laurentiis Michele; Arpino Grazia; Massarelli Erminia; Ruggiero Angela; Carlomagno Chiara; Ciardiello Fortunato; Tortora Giampaolo; D'Agostino Diego; Caputo Francesca; Cancello Giuseppe; Montagna Emilia; Malorni Luca; Zinno Luigia; Lauria Rossella; Bianco Angelo Raffaele; De Placido Sabino
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4741-8.
2005: Morelli M P; Cascone T; Troiani T; De Vita F; Orditura M; Laus G; Eckhardt S G; Pepe S; Tortora G; Ciardiello F
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv61-68.
2005: De Vita F; Orditura M; Ciardiello F; Catalano G
Adjuvant chemotherapy of gastric cancer: which regimens?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv102-105.
2005: Bianco R; Daniele G; Ciardiello F; Tortora G
Monoclonal antibodies targeting the epidermal growth factor receptor.
Current drug targets 2005;6(3):275-87.
2005: De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema M R; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco A R
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
British journal of cancer 2005;92(9):1644-9.
2005: Ciardiello Fortunato
Epidermal growth factor receptor inhibitors in cancer treatment.
Future oncology (London, England) 2005;1(2):221-34.
2005: Ciardiello Fortunato; De Vita Ferdinando; Orditura Michele; Comunale Daniela; Galizia Gennaro
Cetuximab in the treatment of colorectal cancer.
Future oncology (London, England) 2005;1(2):173-81.
2005: Gridelli C; Maione P; Rossi A; Ciardiello F; Raben D
Treatment of locally advanced non-small cell lung cancer in the elderly.
Current opinion in oncology 2005;17(2):130-4.
2005: Bianco Roberto; Ciardiello Fortunato; Tortora Giampaolo
Chemosensitization by antisense oligonucleotides targeting MDM2.
Current cancer drug targets 2005;5(1):51-6.
2005: Tuccillo Concetta; Romano Marco; Troiani Teresa; Martinelli Erika; Morgillo Floriana; De Vita Ferdinando; Bianco Roberto; Fontanini Gabriella; Bianco Raffaele A; Tortora Giampaolo; Ciardiello Fortunato
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1268-76.
2005: Raben David; Helfrich Barb; Chan Daniel C; Ciardiello Fortunato; Zhao LiMin; Franklin Wilbur; Barón Anna E; Zeng Chan; Johnson Tim K; Bunn Paul A
The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):795-805.
2005: Ciardiello Fortunato; De Vita Ferdinando
Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy.
Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques 2005;63():93-114.
2004: Gridelli Cesare; Massarelli Erminia; Maione Paolo; Rossi Antonio; Herbst Roy S; Onn Amir; Ciardiello Fortunato
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
Cancer 2004;101(8):1733-44.
2004: Normanno Nicola; De Luca Antonella; Maiello Monica R; Bianco Caterina; Mancino Mario; Strizzi Luigi; Arra Claudio; Ciardiello Fortunato; Agrawal Sudhir; Salomon David S
CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.
International journal of oncology 2004;25(4):1013-20.
2004: Bianco Caterina; Normanno Nicola; Salomon David S; Ciardiello Fortunato
Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
Growth factors (Chur, Switzerland) 2004;22(3):133-9.
2004: Orditura Michele; Quaglia Fabiana; Morgillo Floriana; Martinelli Erika; Lieto Eva; De Rosa Giuseppe; Comunale Daniela; Diadema Maria Rosaria; Ciardiello Fortunato; Catalano Giuseppe; De Vita Ferdinando
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review).
Oncology reports 2004;12(3):549-56.
2004: Raben David; Bianco Cataldo; Damiano Vincenzo; Bianco Roberto; Melisi Davide; Mignogna Chiara; D'Armiento Francesco Paolo; Cionini Luca; Bianco A Raffaele; Tortora Giampaolo; Ciardiello Fortunato; Bunn Paul
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Molecular cancer therapeutics 2004;3(8):977-83.
2004: Bianco Roberto; Caputo Roberta; Caputo Rosa; Damiano Vincenzo; De Placido Sabino; Ficorella Corrado; Agrawal Sudhir; Bianco A Raffaele; Ciardiello Fortunato; Tortora Giampaolo
Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4858-64.
2004: Galizia Gennaro; Lieto Eva; Ferraraccio Francesca; Orditura Michele; De Vita Ferdinando; Castellano Paolo; Imperatore Vincenzo; Romano Ciro; Ciardiello Fortunato; Agostini Bruno; Pignatelli Carlo
Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3490-9.
2004: Ciardiello Fortunato; De Vita Ferdinando; Orditura Michele; Tortora Giampaolo
The role of EGFR inhibitors in nonsmall cell lung cancer.
Current opinion in oncology 2004;16(2):130-5.
2004: Melisi D; Troiani T; Damiano V; Tortora G; Ciardiello F
Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.
Endocrine-related cancer 2004;11(1):51-68.
2004: Ciardiello Fortunato; Bianco Roberto; Caputo Roberta; Caputo Rosa; Damiano Vincenzo; Troiani Teresa; Melisi Davide; De Vita Ferdinando; De Placido Sabino; Bianco A Raffaele; Tortora Giampaolo
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):784-93.
2004: De Vita Ferdinando; Orditura Michele; Lieto Eva; Infusino Stefania; Morgillo Floriana; Martinelli Erika; Castellano Paolo; Romano Ciro; Ciardiello Fortunato; Catalano Giuseppe; Pignatelli Carlo; Galizia Gennaro
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.
Cancer 2004;100(2):270-8.
2004: Tortora Giampaolo; Melisi Davide; Ciardiello Fortunato
Angiogenesis: a target for cancer therapy.
Current pharmaceutical design 2004;10(1):11-26.
2003: Tortora Giampaolo; Ciardiello Fortunato
Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapy.
Annals of the New York Academy of Sciences 2003;1002():236-43.
2003: Ciardiello Fortunato; De Vita Ferdinando; Orditura Michele; De Placido Sabino; Tortora Giampaolo
Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials.
Expert opinion on emerging drugs 2003;8(2):501-14.
2003: Tortora Giampaolo; Ciardiello Fortunato
Antisense strategies targeting protein kinase C: preclinical and clinical development.
Seminars in oncology 2003;30(4 Suppl 10):26-31.
2003: Raben David; Helfrich Barb; Ciardiello Fortunato; Bunn Paul A
Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S15-22.
2003: Ciardiello F; Tortora Giampaolo
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.
European journal of cancer (Oxford, England : 1990) 2003;39(10):1348-54.
2003: Lorenzo Giuseppe Di; Bianco Roberto; Tortora Giampaolo; Ciardiello Fortunato
Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence.
Clinical prostate cancer 2003;2(1):50-7.
2003: Caputo Rosa; Tuccillo Concetta; Manzo Barbara A; Zarrilli Raffaele; Tortora Giampaolo; Blanco Camillo Del Vecchio; Ricci Vittorio; Ciardiello Fortunato; Romano Marco
Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2015-21.
2003: Tortora Giampaolo; Caputo Rosa; Damiano Vincenzo; Melisi Davide; Bianco Roberto; Fontanini Gabriella; Veneziani Bianca Maria; De Placido Sabino; Bianco A Raffaele; Ciardiello Fortunato
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1566-72.
2003: Ciardiello Fortunato; Caputo Rosa; Damiano Vincenzo; Caputo Roberta; Troiani Teresa; Vitagliano Donatella; Carlomagno Francesca; Veneziani Bianca Maria; Fontanini Gabriella; Bianco A Raffaele; Tortora Giampaolo
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1546-56.
2003: Di Lorenzo Giuseppe; Autorino Riccardo; Ciardiello Fortunato; Raben David; Bianco Cataldo; Troiani Teresa; Pizza Carmine; De Laurentiis Michele; Pensabene Matilde; D'Armiento Massimo; Bianco A Raffaele; De Placido Sabino
External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.
Oncology reports 2003;10(2):399-404.
2003: Tortora Giampaolo; Caputo Rosa; Damiano Vincenzo; Caputo Roberta; Troiani Teresa; Veneziani Bianca Maria; De Placido Sabino; Bianco Angelo Raffaele; Zangemeister-Wittke Uwe; Ciardiello Fortunato
Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):866-71.
2002: Carlomagno Francesca; Vitagliano Donata; Guida Teresa; Ciardiello Fortunato; Tortora Giampaolo; Vecchio Giancarlo; Ryan Anderson J; Fontanini Gabriella; Fusco Alfredo; Santoro Massimo
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.
Cancer research 2002;62(24):7284-90.
2002: Tortora Giampaolo; Ciardiello Fortunato
[Rationales for the integration of molecular and conventional therapies]
Tumori 2002;88(6):A9-13.
2002: Di Lorenzo Giuseppe; Tortora Giampaolo; D'Armiento Francesco P; De Rosa Gaetano; Staibano Stefania; Autorino Riccardo; D'Armiento Massimo; De Laurentiis Michele; De Placido Sabino; Catalano Giuseppe; Bianco A Raffaele; Ciardiello Fortunato
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3438-44.
2002: Bianco Cataldo; Tortora Giampaolo; Bianco Roberto; Caputo Roberta; Veneziani Bianca Maria; Caputo Rosa; Damiano Vincenzo; Troiani Teresa; Fontanini Gabriella; Raben David; Pepe Stefano; Bianco A Raffaele; Ciardiello Fortunato
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3250-8.
2002: Raben David; Bianco Cataldo; Helfrich Barb; Weng Elaine; Ciardiello Fortunato; Harari Paul
Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment.
Expert review of anticancer therapy 2002;2(4):461-71.
2002: Ciardiello Fortunato
The rational basis of using novel targeted biological agents in non-small cell lung cancer.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S31-3.
2002: Tortora Giampaolo; Ciardiello Fortunato
Protein kinase A as target for novel integrated strategies of cancer therapy.
Annals of the New York Academy of Sciences 2002;968():139-47.
2002: Ciardiello Fortunato; Tortora Giampaolo
Anti-epidermal growth factor receptor drugs in cancer therapy.
Expert opinion on investigational drugs 2002;11(6):755-68.
2002: Tortora G; Ciardiello F; Damiano V; De Laurentiis M; Matano E; Pepe S; Pensabene M; Catalano G; De Placido S; Bianco A R
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):392-8.
2002: Ciardiello Fortunato; Caputo Rosa; Borriello Gaetano; Del Bufalo Donatella; Biroccio Annamaria; Zupi Gabriella; Bianco A Raffaele; Tortora Giampaolo
ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells.
International journal of cancer. Journal international du cancer 2002;98(3):463-9.
2002: Tortora Giampaolo; Ciardiello Fortunato
Protein kinase A type I: a target for cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):303-4.
2002: Ciardiello Fortunato; Tortora Giampaolo; De Placido Sabino; Bianco A Raffaele
ZD1839 (Iressa): preclinical studies and pharmacology.
Tumori 2002;88(1 Suppl 1):S155-7.
2002: Normanno N; Campiglio M; De Luca A; Somenzi G; Maiello M; Ciardiello F; Gianni L; Salomon D S; Menard S
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(1):65-72.
2002: Ciardiello F
An update of new targets for cancer treatment: receptor-mediated signals.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():29-38.
2001: Tortora G; Caputo R; Damiano V; Fontanini G; Melisi D; Veneziani B M; Zunino F; Bianco A R; Ciardiello F
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4156-63.
2001: Ciardiello F; Tortora G
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):2958-70.
2001: Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco A R; Ciardiello F
Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2537-44.
2001: Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla E R; Agrawal S; Mendelsohn J; Bianco A R; Tortora G
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
International journal of cancer. Journal international du cancer 2001;93(2):172-8.
2001: Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco A R; Tortora G
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1459-65.
2000: Tortora G; Caputo R; Damiano V; Bianco R; Chen J; Agrawal S; Bianco A R; Ciardiello F
A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer.
International journal of cancer. Journal international du cancer 2000;88(5):804-9.
2000: De Luca A; Arra C; D'Antonio A; Casamassimi A; Losito S; Ferraro P; Ciardiello F; Salomon D S; Normanno N
Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.
Oncogene 2000;19(51):5863-71.
2000: Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco A R; Ciardiello F
Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4343-50.
2000: Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco A R; Mendelsohn J; Tortora G
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3739-47.
2000: Tortora G; Ciardiello F
Targeting of epidermal growth factor receptor and protein kinase A: molecular basis and therapeutic applications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):777-83.
2000: Indolfi C; Di Lorenzo E; Rapacciuolo A; Stingone A M; Stabile E; Leccia A; Torella D; Caputo R; Ciardiello F; Tortora G; Chiariello M
8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo.
Journal of the American College of Cardiology 2000;36(1):288-93.
2000: Tortora G; Bianco R; Damiano V; Fontanini G; De Placido S; Bianco A R; Ciardiello F
Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2506-12.
2000: Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco A R; Tortora G
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):2053-63.
2000: Ciardiello F; Caputo R; Pomatico G; De Laurentiis M; De Placido S; Bianco A R; Tortora G
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A.
International journal of cancer. Journal international du cancer 2000;85(5):710-5.
2000: Ciardiello F
Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents.
Drugs 2000;60 Suppl 1():25-32; discussion 41-2.
1999: De Placido S; Carlomagno C; Ciardiello F; De Laurentiis M; Pepe S; Ruggiero A; Tortora G; Panico L; D'Antonio A; Pettinato G; Petrella G; Bianco A R
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2854-9.
1999: Normanno N; Tortora G; De Luca A; Pomatico G; Casamassimi A; Agrawal S; Mendelsohn J; Bianco A R; Ciardiello F
Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
Oncology reports 1999;6(5):1105-9.
1999: Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco A R; Tortora G
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):909-16.
1999: Tortora G; Caputo R; Pomatico G; Pepe S; Bianco A R; Agrawal S; Mendelsohn J; Ciardiello F
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):875-81.
1999: De Luca A; Casamassimi A; Selvam M P; Losito S; Ciardiello F; Agrawal S; Salomon D S; Normanno N
EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells.
International journal of cancer. Journal international du cancer 1999;80(4):589-94.
1998: Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco A R; Agrawal S; Mendelsohn J; Tortora G
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Journal of the National Cancer Institute 1998;90(14):1087-94.
1998: Tortora G; Caputo R; Damiano V; Bianco R; Pepe S; Pomatico G; Bianco A R; Jiang Z; Agrawal S; Ciardiello F
Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents.
Antisense & nucleic acid drug development 1998;8(2):141-5.
1998: Ciardiello F; Tortora G
Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(4):821-8.
1998: Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco A R; Gullick W; Angeletti C A; Bevilacqua G; Ciardiello F
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):241-9.
1998: Ciardiello F; Dixit M; di Isernia G; Damiano V; Bianco R; Bianco A R; Arteaga C L; Tortora G
Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector.
Breast cancer research and treatment 1998;47(1):57-62.
1997: Tortora G; di Isernia G; Sandomenico C; Bianco R; Pomatico G; Pepe S; Bianco A R; Ciardiello F
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells.
Cancer research 1997;57(22):5107-11.
1997: Tortora G; Caputo R; Damiano V; Bianco R; Pepe S; Bianco A R; Jiang Z; Agrawal S; Ciardiello F
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12586-91.
1997: De Luca A; Selvam M P; Sandomenico C; Pepe S; Bianco A R; Ciardiello F; Salomon D S; Normanno N
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.
International journal of cancer. Journal international du cancer 1997;73(2):277-82.
1997: Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti C A; Bevilacqua G
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
Journal of the National Cancer Institute 1997;89(12):881-6.
1997: Normanno N; Ciardiello F
EGF-related peptides in the pathophysiology of the mammary gland.
Journal of mammary gland biology and neoplasia 1997;2(2):143-51.
1997: Bianco C; Tortora G; Baldassarre G; Caputo R; Fontanini G; Chinè S; Bianco A R; Ciardiello F
8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):439-48.
1997: Tortora G; Damiano V; Bianco C; Baldassarre G; Bianco A R; Lanfrancone L; Pelicci P G; Ciardiello F
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor.
Oncogene 1997;14(8):923-8.
1997: Bianco A R; Carlomagno C; De Laurentiis M; De Placido S; Tortora G; Ciardiello F
Prognostic factors in human colorectal cancer.
Tumori 1997;83(1 Suppl):S15-8.
1996: Ciardiello F; Damiano V; Bianco R; Bianco C; Fontanini G; De Laurentiis M; De Placido S; Mendelsohn J; Bianco A R; Tortora G
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
Journal of the National Cancer Institute 1996;88(23):1770-6.
1996: Baldassarre G; Bianco C; Tortora G; Ruggiero A; Moasser M; Dmitrovsky E; Bianco A R; Ciardiello F
Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line.
International journal of cancer. Journal international du cancer 1996;66(4):538-43.
1996: Normanno N; Bianco C; Damiano V; de Angelis E; Selvam M P; Grassi M; Magliulo G; Tortora G; Bianco A R; Mendelsohn J; Salomon D S; Ciardiello F
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):601-9.
1996: Mincione G; Bianco C; Kannan S; Colletta G; Ciardiello F; Sliwkowski M; Yarden Y; Normanno N; Pramaggiore A; Kim N; Salomon D S
Enhanced expression of heregulin in c-erb B-2 and c-Ha-ras transformed mouse and human mammary epithelial cells.
Journal of cellular biochemistry 1996;60(4):437-46.
1996: Tagliaferri P; Tortora G; Guarrasi R; Damiano V; Ruggiero A; Morelli D; Caraglia M; Bianco R; di Isernia G; Pepe S; Arteaga C L; Langton-Webster B C; Bianco A R; Ciardiello F
Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):207-14.
1996: Panico L; D'Antonio A; Salvatore G; Mezza E; Tortora G; De Laurentiis M; De Placido S; Giordano T; Merino M; Salomon D S; Mullick W J; Pettinato G; Schnitt S J; Bianco A R; Ciardiello F
Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues.
International journal of cancer. Journal international du cancer 1996;65(1):51-6.
1995: Normanno N; Kim N; Wen D; Smith K; Harris A L; Plowman G; Colletta G; Ciardiello F; Salomon D S
Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas.
Breast cancer research and treatment 1995;35(3):293-7.
1995: Normanno N; Selvam M P; Bianco C; Damiano V; de Angelis E; Grassi M; Magliulo G; Tortora G; Salomon D S; Ciardiello F
Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line.
International journal of cancer. Journal international du cancer 1995;62(6):762-6.
1995: Salomon D S; Brandt R; Ciardiello F; Normanno N
Epidermal growth factor-related peptides and their receptors in human malignancies.
Critical reviews in oncology/hematology 1995;19(3):183-232.
1995: Caraglia M; Leardi A; Corradino S; Ciardiello F; Budillon A; Guarrasi R; Bianco A R; Tagliaferri P
alpha-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells.
International journal of cancer. Journal international du cancer 1995;61(3):342-7.
1995: Caligo M A; Cipollini G; Fiore L; Calvo S; Basolo F; Collecchi P; Ciardiello F; Pepe S; Petrini M; Bevilacqua G
NM23 gene expression correlates with cell growth rate and S-phase.
International journal of cancer. Journal international du cancer 1995;60(6):837-42.
1995: Ciardiello F; Damiano V; Bianco C; di Isernia G; Ruggiero A; Caraglia M; Tagliaferri P; Baselga J; Mendelsohn J; Bianco A R
Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(2):161-7.
1995: Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies S L; North P; Harris A L; Hickson I D
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):49-56.
1995: Salomon D S; Normanno N; Ciardiello F; Brandt R; Shoyab M; Todaro G J
The role of amphiregulin in breast cancer.
Breast cancer research and treatment 1995;33(2):103-14.
1994: Tortora G; Pepe S; Bianco C; Damiano V; Ruggiero A; Baldassarre G; Corbo C; Cho-Chung Y S; Bianco A R; Ciardiello F
Differential effects of protein kinase A sub-units on Chinese-hamster-ovary cell cycle and proliferation.
International journal of cancer. Journal international du cancer 1994;59(5):712-6.
1994: Tortora G; Pepe S; Bianco C; Baldassarre G; Budillon A; Clair T; Cho-Chung Y S; Bianco A R; Ciardiello F
The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells.
Oncogene 1994;9(11):3233-40.
1994: Sabbatini A R; Basolo F; Valentini P; Mattii L; Calvo S; Fiore L; Ciardiello F; Petrini M
Induction of multidrug resistance (MDR) by transfection of MCF-10A cell line with c-Ha-ras and c-erbB-2 oncogenes.
International journal of cancer. Journal international du cancer 1994;59(2):208-11.
1994: North P S; Davies S L; Ciardiello F; Damiano V; Bianco C; Pepe S; Bianco A R; Harris A L; Hickson I D; Tortora G
Overexpression of the RI alpha subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3'5'-monophosphate in Chinese hamster ovary cells.
Cancer research 1994;54(15):4123-8.
1994: Brandt R; Normanno N; Gullick W J; Lin J H; Harkins R; Schneider D; Jones B W; Ciardiello F; Persico M G; Armenante F
Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.
The Journal of biological chemistry 1994;269(25):17320-8.
1994: Qi C F; Liscia D S; Normanno N; Merlo G; Johnson G R; Gullick W J; Ciardiello F; Saeki T; Brandt R; Kim N
Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
British journal of cancer 1994;69(5):903-10.
1994: Basolo F; Fiore L; Ciardiello F; Calvo S; Fontanini G; Conaldi P G; Toniolo A
Response of normal and oncogene-transformed human mammary epithelial cells to transforming growth factor beta 1 (TGF-beta 1): lack of growth-inhibitory effect on cells expressing the simian virus 40 large-T antigen.
International journal of cancer. Journal international du cancer 1994;56(5):736-42.
1994: Normanno N; Selvam M P; Qi C F; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R
Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2790-4.
1994: Ciardiello F; Tortora G; Bianco C; Selvam M P; Basolo F; Fontanini G; Pacifico F; Normanno N; Brandt R; Persico M G
Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
Oncogene 1994;9(1):291-8.
1994: Pepe S; Ruggiero A; Tortora G; Ciardiello F; Garbi C; Yokozaki H; Cho-Chung Y S; Clair T; Skalhegg B S; Bianco A R
Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells.
Cytometry 1994;15(1):73-9.
1994: Normanno N; Ciardiello F; Brandt R; Salomon D S
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.
Breast cancer research and treatment 1994;29(1):11-27.
1993: Mincione G; Cirafici A M; Lazzareschi D; Pepe S; Ciardiello F; Colletta G
Loss of thyrotropin regulation and transforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells.
Cancer research 1993;53(22):5548-53.
1993: Ciardiello F; Tortora G; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam M P; Bianco A R
Reduction of RI alpha subunit of cAMP-dependent protein kinase expression induces growth inhibition of human mammary epithelial cells transformed by TGF-alpha, c-Ha-ras, and c-erbB-2 genes.
Annals of the New York Academy of Sciences 1993;698():102-7.
1993: Kenney N J; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin M B; Normanno N; Ciardiello F; Day A; Cutler M L
Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
Journal of cellular physiology 1993;156(3):497-514.
1993: Ciardiello F; Bianco C; Normanno N; Baldassarre G; Pepe S; Tortora G; Bianco A R; Salomon D S
Infection with a transforming growth factor alpha anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line.
International journal of cancer. Journal international du cancer 1993;54(6):952-8.
1993: Tortora G; Pepe S; Cirafici A M; Ciardiello F; Porcellini A; Clair T; Colletta G; Cho-Chung Y S; Bianco A R
Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(5):359-65.
1993: Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam M P; Bianco A R; Tortora G
Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
International journal of cancer. Journal international du cancer 1993;53(3):438-43.
1992: Basolo F; Serra C; Ciardiello F; Fiore L; Russo J; Campani D; Dolei A; Squartini F; Toniolo A
Regulation of surface-differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene.
International journal of cancer. Journal international du cancer 1992;51(4):634-40.
1992: Saeki T; Stromberg K; Qi C F; Gullick W J; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson G R; Salomon D S
Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
Cancer research 1992;52(12):3467-73.
1992: Venesio T; Taverna D; Hynes N E; Deed R; MacAllan D; Ciardiello F; Valverius E M; Salomon D S; Callahan R; Merlo G
The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1992;3(1):63-71.
1992: Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson R B; Bianco A R; Salomon D S
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Molecular carcinogenesis 1992;6(1):43-52.
1991: Saeki T; Cristiano A; Lynch M J; Brattain M; Kim N; Normanno N; Kenney N; Ciardiello F; Salomon D S
Regulation by estrogen through the 5'-flanking region of the transforming growth factor alpha gene.
Molecular endocrinology (Baltimore, Md.) 1991;5(12):1955-63.
1991: Ciardiello F; Kim N; Saeki T; Dono R; Persico M G; Plowman G D; Garrigues J; Radke S; Todaro G J; Salomon D S
Differential expression of epidermal growth factor-related proteins in human colorectal tumors.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(17):7792-6.
1991: Colletta G; Cirafici A M; Di Carlo A; Ciardiello F; Salomon D S; Vecchio G
Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells.
Oncogene 1991;6(4):583-7.
1991: Ciardiello F; Kim N; McGeady M L; Liscia D S; Saeki T; Bianco C; Salomon D S
Expression of transforming growth factor alpha (TGF alpha) in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(3):169-82.
1991: Ciardiello F; Dono R; Kim N; Persico M G; Salomon D S
Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line.
Cancer research 1991;51(3):1051-4.
1991: Salomon D S; Ciardiello F; Valverius E M; Kim N
The role of ras gene expression and transforming growth factor alpha production in the etiology and progression of rodent and human breast cancer.
Cancer treatment and research 1991;53():107-57.
1990: Salomon D S; Kim N; Saeki T; Ciardiello F
Transforming growth factor-alpha: an oncodevelopmental growth factor.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1990;2(12):389-97.
1990: Valverius E M; Ciardiello F; Heldin N E; Blondel B; Merlo G; Smith G; Stampfer M R; Lippman M E; Dickson R B; Salomon D S
Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
Journal of cellular physiology 1990;145(2):207-16.
1990: Merlo G R; Blondel B J; Deed R; MacAllan D; Peters G; Dickson C; Liscia D S; Ciardiello F; Valverius E M; Salomon D S
The mouse int-2 gene exhibits basic fibroblast growth factor activity in a basic fibroblast growth factor-responsive cell line.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(10):463-72.
1990: Valverius E M; Velu T; Shankar V; Ciardiello F; Kim N; Salomon D S
Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype.
International journal of cancer. Journal international du cancer 1990;46(4):712-8.
1990: Ciardiello F; McGeady M L; Kim N; Basolo F; Hynes N; Langton B C; Yokozaki H; Saeki T; Elliott J W; Masui H
Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(9):407-20.
1990: Yanagihara K; Ciardiello F; Talbot N; McGeady M L; Cooper H; Benade L; Salomon D S; Bassin R H
Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
Oncogene 1990;5(8):1179-86.
1990: Hynes N E; Taverna D; Harwerth I M; Ciardiello F; Salomon D S; Yamamoto T; Groner B
Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.
Molecular and cellular biology 1990;10(8):4027-34.
1990: Liscia D S; Merlo G; Ciardiello F; Kim N; Smith G H; Callahan R; Salomon D S
Transforming growth factor-alpha messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization.
Developmental biology 1990;140(1):123-31.
1990: Ciardiello F; Valverius E M; Colucci-D'Amato G L; Kim N; Bassin R H; Salomon D S
Differential growth factor expression in transformed mouse NIH-3T3 cells.
Journal of cellular biochemistry 1990;42(1):45-57.
1990: Ciardiello F; Tortora G; Kim N; Clair T; Ally S; Salomon D S; Cho-Chung Y S
8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation.
The Journal of biological chemistry 1990;265(2):1016-20.
1989: McGeady M L; Kerby S; Shankar V; Ciardiello F; Salomon D; Seidman M
Infection with a TGF-alpha retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts.
Oncogene 1989;4(11):1375-82.
1989: Ciardiello F; Kim N; Liscia D S; Bianco C; Lidereau R; Merlo G; Callahan R; Greiner J; Szpak C; Kidwell W
mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients.
Journal of the National Cancer Institute 1989;81(15):1165-71.
1989: Ciardiello F; Hynes N; Kim N; Valverius E M; Lippman M E; Salomon D S
Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-alpha production.
FEBS letters 1989;250(2):474-8.
1989: Tortora G; Ciardiello F; Ally S; Clair T; Salomon D S; Cho-Chung Y S
Site-selective 8-chloroadenosine 3',5'-cyclic monophosphate inhibits transformation and transforming growth factor alpha production in Ki-ras-transformed rat fibroblasts.
FEBS letters 1989;242(2):363-7.
1989: Shankar V; Ciardiello F; Kim N; Derynck R; Liscia D S; Merlo G; Langton B C; Sheer D; Callahan R; Bassin R H
Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA.
Molecular carcinogenesis 1989;2(1):1-11.
1989: Salomon D S; Kidwell W R; Kim N; Ciardiello F; Bates S E; Valverius E; Lippman M E; Dickson R B; Stampfer M
Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;113():57-69.
1989: Salomon D S; Ciardiello F; Valverius E; Saeki T; Kim N
Transforming growth factors in human breast cancer.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1989;43(9):661-7.
1988: Ciardiello F; Kim N; Hynes N; Jaggi R; Redmond S; Liscia D S; Sanfilippo B; Merlo G; Callahan R; Kidwell W R
Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.
Molecular endocrinology (Baltimore, Md.) 1988;2(12):1202-16.
1988: Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin R H; Kidwell W R; Salomon D S
Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
Cancer research 1988;48(9):2483-91.
1988: Sanfilippo B; Ciardiello F; Salomon D S; Kidwell W R
Growth of cells on a perfluorocarbon-medium interphase: a quantitative assay for anchorage-independent cell growth.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1988;24(1):71-8.
1988: Bhattacharya B; Ciardiello F; Salomon D S; Cooper H L
Disordered metabolism of microfilament proteins, tropomyosin and actin, in mouse mammary epithelial cells expressing the Ha-ras oncogene.
Oncogene research 1988;3(1):51-65.
1987: Tagliaferri P; Yanagihara K; Ciardiello F; Talbot N; Flatow U; Benade L; Bassin R H
Effects of ouabain on NIH/3T3 cells transformed with retroviral oncogenes and on human tumor cell lines.
International journal of cancer. Journal international du cancer 1987;40(5):653-8.

Sign-in to see more